Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma
Summary
The purpose of this phase II study is to determine 1) if there is an increase in share of patients able to undergo curative surgery and 2) improve the local disease control interval and extend survival for patients who remain unresectable.
General Information
NCT#: NCT02598349
Study ID: PAN009-18
Trial Phase: Phase II
Trial Sponsor: Proton Collaborative Group
Therapies Used in This Trial: Capecitabine, Proton Radiation, Surgery